Pearl Abyss closed April 27 at ₩60,200 (+5.61%), not via foreign-led mass buying, but by absorbing 75,930 shares of official short-selling, foreign-house net selling, and Kiwoom-led retail outflow with Shinhan/Korea Investment-led institutional buying. Short VWAP at ₩60,390 vs close ₩60,200 makes ₩60,400 an important next-session factor. ₩60,000 is now a first-line support candidate, not a resistance.
KOSPI surges +2.5% in a semis and power-equipment risk-on session; the PEAD screener flags Hanwha Vision, Woowon Development, Pharmicell and Bosung Powertech among the key earnings-drift names.
Part 2 of the Upstage AI thesis: how Korea's sovereign AI program, public-sector AX demand, AI voucher adoption, the Daum acquisition, B2C agents and MiniMax/Zhipu IPO peers can reshape Upstage's path to listing.
Crimson Desert's first full post-1.04.00 weekend (April 25–27 KST): average CCU -13.2% vs prior weekend, but new negative reviews -49.7%, new-review positivity +8.7pp to 87.3%, and US Steam rank improved #6.0 → #5.1. Sales run-rate decay (-5.7%) is materially shallower than CCU decay (-13.2%) — exactly the long-tail signature the platform-rerating thesis predicts.
Upstage AI has become Korea's first generative AI unicorn. The real thesis is not a consumer chatbot story, but a sovereign AI and enterprise document-intelligence platform built around Solar, Document Parse, AMD/AWS infrastructure and Japan expansion.
The SK Telecom re-rating is not a 'dividend normalization' story. It's a recombination of telco core cash flow + Anthropic equity + AIDC/GPUaaS + Edge AI/AI-RAN/Network API options. At ₩100,000 the first leg is largely priced in. The next factors are price support below ₩90,000, 1Q/2Q dividend recovery, earnings, and AIDC growth confirmation.
The Pearl Abyss thesis has moved past unit sales. The real question: can Crimson Desert force the market to reclassify Pearl Abyss from 'one-off package hit' to 'global AAA platform / proprietary-engine company'? 5M units, 1.04.00 patch, 95.8% post-patch review positivity, and persistent short balance say the option is mispriced — but not yet proven.
Neosem (253590 KQ) is a Korean ATE company leveraged to PCIe Gen6 SSD testers, CXL 3.1 memory testers, server DIMM automation, SOCAMM and potentially HBM burn-in. 2025 was a sharp downcycle, but late-2025 orders point to a possible 2026 revenue inflection.
OpenEdges Technology (394280 KQ) is not a CXL equipment trade. It is Korea's rare semiconductor IP platform: memory controller, DDR PHY, NPU, NoC, UCIe and CXL-adjacent memory IP, with near-term losses but a long-duration royalty option.
A critical re-read of the consensus 'Neosem = Core / OpenEdge = long-dated option / Exicon = afterthought' framing. Once you separate the CXL purity prism from the 2026 earnings-momentum prism, Exicon (092870 KQ) emerges as the strongest near-term J-curve — KRW 79B in cumulative orders against 2024 revenue of KRW 31.6B, single-source CLT 11,520-parallel tester, Samsung qualified. Neosem is a mid-cycle bet that needs 1Q26 confirmation. OpenEdge stays a 3-5 year IP option with royalty mix at 0.4%.